Follow-Up Estradiol Levels Based on Regimen Formulation With Guideline-Concordant Gender-Affirming Hormone Therapy
Supratherapeutic follow-up estradiol levels were common with guideline-concordant parenteral estradiol doses, as were subtherapeutic follow-up levels with guideline-concordant transdermal doses. These findings may suggest the need for revision of guideline-recommended estradiol doses for these formulations.
Authors
- C. Domínguez (ORCID: https://orcid.org/0000-0003-4626-0118)
- Matthew J. Crowley (ORCID: https://orcid.org/0000-0002-6205-4536)
- Athavi Jeevananthan
- Scott M Carlson (ORCID: https://orcid.org/0000-0002-7012-4127)
Institutions
- Duke University (US)
- Durham VA Health Care System (US)
- Durham VA Medical Center (US)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1210/jendso/bvae205
- Citations
- 2
- Primary Topic
- Estrogen and related hormone effects
- Type
- article
- Field-Weighted Citation Impact
- 1.10
Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health
- Quality Enhancement Research Initiative
- Office of Rural Health